We are excited to announce that our next ADC Working Group meeting will be held on February 24th. During this session, we will focus on Session 2 of the FDA webinar, specifically the "Final Guidance: Clinical Pharmacology Considerations for Antibody-Drug Conjugates" and the Q&A from session 2.
Link to Teams Meeting: Join the meeting now
Time: 3pm CST - 4pm CST
To ensure we have a productive and engaging discussion, please watch the webinar prior to our meeting and bring any notes or questions you may have. You can access the webinar here: https://www.fda.gov/drugs/news-events-human-drugs/clinical-pharmacology-considerations-novel-therapeutic-modalities-12042024#event-information
We look forward to your participation and a lively discussion!
------------------------------
Soumya Mohana Sundaram M.S.
Associate Director
Celerion
Lincoln NE
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------